Filer Snapshot

Anthony S. Marucci

CIK 0001429933. SEC filing timeline plus parsed ownership intelligence from 13F, 13D/G, and Forms 3/4/5 where available.

Entity type

Individual

Total filings

5

Latest filing

20 Jun 2023

Industry

n/a

Filing-backed research brief

Start with the SEC data that changes for this CIK

Latest signal: Forms 3/4/5 owner position for CLDX. Each card links back to the PortfolioSavvy page where the filing evidence is closest.

Largest parsed holding

Populates from the latest parsed 13F information table.

Open holding

13D/G large stake

No recent parsed 13D/G stake row for this CIK.

Browse 13D/G

Save this filer page

Create a free account to keep this page in your watchlists. After verification, we will save it automatically and open your saved research list.

Source: SEC Forms 3/4/5

4 filed on 20 Jun 2023 for CIK 0001429933.

View Source Filing
SEC ownership signals 1 fact
Ownership signals from SEC filings

Filing-value scale

Bars compare parsed values by filing family; they are not one combined total.

Forms 3/4/5 positions$1.08M

Reporting-owner positions when values can be estimated.

Forms 3/4/5 position value

$1.08M

Estimated from parsed Forms 3/4/5 when the filing discloses enough data.

Top issuer positions

Top parsed positions across ownership filing types.

CLDX
How to read these values
  • Filing families stay separate: 13F portfolio value, 13D/G large stakes, and Forms 3/4/5 owner positions should not be blended into one total.
  • Use the linked research paths to verify each signal against the original SEC filing.
Filer identity 1 fact
Business address
C/O Celldex Therapeutics, Inc, 53 Frontage Road, Suite 220, Hampton, NJ, 08827

Filer intelligence

What SEC filings say about Anthony S. Marucci

A compact read of parsed XML filings. 13F, 13D/G, and Forms 3/4/5 are shown separately because they answer different ownership questions.

Quick read

  • Forms 3/4/5 show insider context for CLDX worth $1.08M.

SEC source mix

Counts show available parsed rows, not one combined ownership total.

XML parsed
13F portfolio No rows yet

Quarterly institutional portfolio holdings.

Open
13D/G stakes No rows yet

Beneficial ownership and large-stake disclosures.

Open
Forms 3/4/5 1 rows

Officer, director, and 10% owner holdings or transactions.

Open

Forms 3/4/5 insider context

CLDX

05 Jun 2025 · PRESIDENT & CEO

$1.08M

Latest update

What changed recently for Anthony S. Marucci

Ownership report updated

Latest ownership report period: 05 Jun 2025. Open the source-backed page to inspect the fresh filing or facts context.

Update date

09 Jun 2025

Page type

Ownership filings

Latest period

05 Jun 2025

Ownership context was refreshed from SEC Forms 3/4/5 filed on 09 Jun 2025.

SEC filing record

CIK 0001429933 filing coverage

Start with this filing record, then use the linked ownership pages when parsed 13F, 13D/G, Forms 3/4/5, or facts data exists for this CIK.

SEC filings
5
First seen
21 Jun 2021
Latest filing
20 Jun 2023
Entity
Individual

Latest Filings

Showing the latest 5 of 5 SEC filings for Anthony S. Marucci.

4

4 filing

Filing date
20 Jun 2023
Reporting date
15 Jun 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
17 Aug 2022
Reporting date
15 Aug 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
17 Jun 2022
Reporting date
16 Jun 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
09 Aug 2021
Reporting date
05 Aug 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
21 Jun 2021
Reporting date
17 Jun 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .